Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
Active, not recruiting · NCT06157567 · Registry updated 2025-08-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Skin and Connective Tissue Diseases, connective tissue disorder, cutis laxa, hereditary disease, hereditary skin disorder, skin disorder | Active, not recruiting | Not applicable | 2025-08-22 | NCT06157567 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Candela Corporation | 6 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Candela European Institue of Excellence | Madrid | Spain | 1 |
| Candela Institue for Excellence | Marlborough | United States | 2 |
| Center for Morden Aesthetic Medicine | Jacksonville | United States | 2 |
| Concierge Medical Arts | Fayetteville | United States | 1 |
| Gerrish MedEsthetics | Vienna | United States | 1 |
| Waterfront Skin and Laser | Vancouver | Canada | 1 |